Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
This article outlines typical volatile periods for SP 500 and how retirees can position portfolios to endure drawdowns while meeting needs.
26,423 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
Two lesser-known mining names outside China are surging as Pentagon demand and Western reshoring reshape the rare ear...
Alphabet is quietly pivoting its AI strategy toward a new growth engine something. This shift could tilt Google Cloud...
Jim Cramer’s steadfast rule on debt service coverage guides stock picks as higher interest rates persist. Investors w...
Mondelez stock inches toward a golden cross as easing cocoa prices and stronger emerging-market demand rally the snac...
The world runs on chips, and ON Semiconductor sits at an important crossroads of EVs, automation, and data centers. T...
Nvidia investors are watching a major update that could define the stock’s next phase. This guide breaks down what to...
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
Pre-IPO momentum for SpaceX is building after AI-focused contracts surface, potentially lifting annual revenue run ra...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...